Login / Signup

Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration.

Gustavo Msm ReisJohn GriggBrian ChuaAnne LeeRidia LimRalph HigginsAlessandra MartinsIvan GoldbergColin I Clement
Published in: Journal of current glaucoma practice (2017)
Reis GMSM, Grigg J, Chua B, Lee A, Lim R, Higgins R, Martins A, Goldberg I, Clement CI. The Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration. J Curr Glaucoma Pract 2017;11(1):3-7.
Keyphrases
  • age related macular degeneration
  • risk factors
  • optic nerve
  • endothelial cells
  • diabetic retinopathy